← Open Payments lookup

NWAMAKA EMERUEM: Open Payments

NPI 1508366642 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,410 in 63 payments from 9 companies in 2025. Trend: 2023 $1,930 · 2024 $1,945 · 2025 $1,410

Food & beverage: $1,404Education: $5
CompanyPaymentsAmount
ABBVIE INC.35$608
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$200
Janssen Pharmaceuticals, Inc5$151
Alkermes, Inc.7$116
Takeda Pharmaceuticals U.S.A., Inc.3$102
E.R. Squibb & Sons, L.L.C.3$72
Neurocrine BioSciences, Inc.3$67
Axsome Therapeutics, Inc.2$62
Corium, LLC1$32

Products named: VRAYLAR, CAPLYTA, ARISTADA, TRINTELLIX, COBENFY, INGREZZA, Auvelity, INVEGA SUSTENNA.

Industry payments across WA — which companies pay providers there.